The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Use of magnetic fields and nanoparticles to trigger drug release and improve tumor targeting
Abstract
Drug delivery strategies aim to maximize a drug's therapeutic index by increasing the concentration of drug at target sites while minimizing delivery to off‐target tissues. Because biological tissues are minimally responsive to magnetic fields, there has been a great deal of interest in using magnetic nanoparticles in combination with applied magnetic fields to selectively control the accumulation and release of drug in target tissues while minimizing the impact on surrounding tissue. In particular, spatially variant magnetic fields have been used to encourage accumulation of drug‐loaded magnetic nanoparticles at target sites, while time‐variant magnetic fields have been used to induce drug release from thermally sensitive nanocarriers. In this review, we discuss nanoparticle formulations and approaches that have been developed for magnetic targeting and/or magnetically induced drug release, as well as ongoing challenges in using magnetism for therapeutic applications. This article is categorized under: Diagnostic Tools > in vivo Nanodiagnostics and Imaging Therapeutic Approaches and Drug Discovery > Emerging Technologies Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another significant problem that must be addressed before DDS can be extensively utilized in medicine is the development of a cost-effective and manufacturable solution [40].”
From Advances in green-synthesized magnetic nanoparticles for targeted cancer therapy: mechanisms, applications, and future perspectives (2026) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1958-5 · Cited by 2,586
Drug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116 · cited 1×
“Unfortunately, these methods are limited by the same challenges as typical biological strategies, including heterogeneous expression of ligands and receptors, and off-target binding (Muro, 2012; Tredan et al., 2007; Vaupel et al., 1989).”
BackgroundMagnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles
Laurent, S., Dutz, S., Häfeli, U. O., & Mahmoudi, M. (2011) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2011.04.003 · Cited by 1,326
New directions in thermoresponsive polymers
Roy, D., Brooks, W. L. A., & Sumerlin, B. S. (2013) · Chemical Society Reviews · doi:10.1039/c3cs35499g · Cited by 1,311
Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems
Nasongkla, N., Bey, E., Ren, J., Ai, H., Khemtong, C., Guthi, J. S., Chin, S.-F., Sherry, A. D., Boothman, D. A., & Gao, J. (2006) · Nano Letters · doi:10.1021/nl061412u · Cited by 1,238
Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION)
Singh, N., Jenkins, G. J. S., Asadi, R., & Doak, S. H. (2010) · Nano Reviews · doi:10.3402/nano.v1i0.5358 · Cited by 1,112
Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review
Kanamala, M., Wilson, W. R., Yang, M., Palmer, B. D., & Wu, Z. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.061 · Cited by 1,004
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles
Arami, H., Khandhar, A., Liggitt, D., & Krishnan, K. M. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00541h · Cited by 830
Guardia, P., Di Corato, R., Lartigue, L., Wilhelm, C., Espinosa, A., Garcia-Hernandez, M., Gazeau, F., Manna, L., & Pellegrino, T. (2012) · ACS Nano · doi:10.1021/nn2048137 · Cited by 752
Tay, Z. W., Chandrasekharan, P., Chiu-Lam, A., Hensley, D. W., Dhavalikar, R., Zhou, X. Y., Yu, E. Y., Goodwill, P. W., Zheng, B., Rinaldi, C., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b00893 · Cited by 459 · cited 4×
“have recently demonstrated spatially specific, tumor targeted hyperthermia with 7 mm resolution in small animal models (Figure 5b) (Tay et al., 2018).”
BackgroundInfluential
Flagged first, then by citations
Research works printed but not linked: 139
- Alexiou C., 2000, Locoregional cancer treatment with magnetic drug targeting, Cancer Research, 60, 6641
- 10.1021/acs.nanolett.6b02261 · DOI · Paper page
- 10.2147/IJN.S145096 · DOI
- 10.1016/B978-0-12-803581-8.10462-X · DOI
- 10.1109/TBME.1984.325372 · DOI
- 10.1016/j.jconrel.2011.06.001 · DOI
- 10.1186/1471-2407-10-119 · DOI
- 10.1039/c3cp55470h · DOI
- 10.1088/0031-9155/60/21/8303 · DOI
- 10.3389/fonc.2015.00165 · DOI
- 10.1016/J.JCONREL.2011.09.098 · DOI
- 10.3390/ma9010029 · DOI
- 10.1039/C4NR06239F · DOI
- 10.1016/J.JCONREL.2016.09.026 · DOI
- 10.3389/fphar.2018.00831 · DOI
- 10.1021/acsnano.7b07572 · DOI
- 10.7150/thno.16684 · DOI
- 10.1021/nn4035266 · DOI
- 10.1021/nn100274v · DOI
- 10.1016/j.colsurfb.2014.01.022 · DOI
- 10.1038/nrd4503 · DOI · Paper page
- 10.1016/j.addr.2006.09.013 · DOI
- 10.3390/nano8110881 · DOI
- 10.7150/thno.30238 · DOI
- 10.1158/1078-0432.CCR-10-3420 · DOI
- 10.1039/C5NR00642B · DOI
- 10.1002/adma.200700091 · DOI
- 10.3109/02656736.2015.1091093 · DOI
- 10.1039/C5BM00166H · DOI
- 10.1016/J.JMMM.2018.02.052 · DOI
- 10.1039/C7CC06410A · DOI
- 10.1038/s41598-018-19628-z · DOI
- 10.1088/0957-4484/27/8/085105 · DOI
- 10.1016/J.JCONREL.2007.12.017 · DOI
- 10.1038/nature03808 · DOI
- Goodman T. T., 2007, Increased nanoparticle penetration in collagenase‐treated multicellular spheroids, International Journal of Nanomedicine, 2, 265
- 10.1039/C5NR06133D · DOI
- 10.1021/acs.langmuir.5b03470 · DOI
- 10.1016/B978-0-08-101997-9.00008-4 · DOI
- 10.1016/J.JCONREL.2017.04.028 · DOI
- 10.1063/1.2830975 · DOI
- 10.1002/bem.22107 · DOI
- 10.1016/j.colsurfb.2016.11.005 · DOI
- 10.1186/s12645-016-0021-x · DOI
- 10.1016/J.MATDES.2017.03.036 · DOI
- 10.1021/acs.inorgchem.7b00956 · DOI
- 10.1039/C5NR07773G · DOI
- 10.1016/J.JCONREL.2015.12.016 · DOI
- 10.1016/J.IJPHARM.2012.03.001 · DOI
- 10.1038/nnano.2010.125 · DOI
- 10.1186/1423-0127-16-86 · DOI
- 10.1002/anie.200805149 · DOI
- 10.1039/B600859C · DOI
- 10.1016/J.BBRC.2015.11.095 · DOI
- 10.1016/J.PHYSLETA.2018.07.051 · DOI
- 10.1021/nn304477s · DOI
- 10.1002/anie.200901791 · DOI
- 10.1016/J.BIOMATERIALS.2013.07.012 · DOI
- 10.1002/anie.201411524 · DOI
- 10.1016/j.biomaterials.2017.03.048 · DOI
- 10.1021/acsami.6b13876 · DOI
- 10.2147/IJN.S128525 · DOI
- 10.4155/tde-2016-0060 · DOI
- 10.1002/smll.201802563 · DOI
- 10.1002/adhm.201600357 · DOI
- Lübbe A. S., 1996, Clinical experiences with magnetic drug targeting: A phase I study with 4′‐epidoxorubicin in 14 patients with advanced solid tumors, Cancer Research, 56, 4686
- 10.1006/JSRE.2000.6030 · DOI
- 10.1007/s12274-015-0729-7 · DOI
- 10.1016/J.ADDR.2015.01.002 · DOI · Paper page
- 10.1016/J.ADDR.2010.05.006 · DOI
- 10.1002/adfm.201402289 · DOI
- 10.1063/1.2713229 · DOI
- 10.1002/adfm.201200307 · DOI
- 10.1002/mrm.21065 · DOI
- 10.1002/smll.201401927 · DOI
- 10.1002/adfm.201101243 · DOI
- 10.1021/acsnano.5b01433 · DOI
- 10.1016/J.BBAGEN.2017.02.025 · DOI · Paper page
- 10.1016/J.ADDR.2018.10.004 · DOI
- 10.1038/nmat3776 · DOI · Paper page
- 10.1016/J.JCONREL.2012.05.052 · DOI
- 10.1016/j.biotechadv.2013.03.005 · DOI
- 10.2147/IJN.S13244 · DOI
- 10.1186/s12989-016-0132-x · DOI
- 10.1002/anie.201306724 · DOI
- 10.1002/anie.200904930 · DOI
- 10.1021/nl301499u · DOI
- 10.1016/J.JCONREL.2013.01.013 · DOI
- 10.1016/j.jcis.2018.08.069 · DOI
- 10.1021/acsami.5b01786 · DOI
- 10.1158/0008-5472.CAN-14-1540 · DOI
- 10.1063/1.4935688 · DOI
- 10.1021/nn3028425 · DOI
- 10.1016/J.BIOMATERIALS.2009.08.005 · DOI
- 10.1016/J.BIOMATERIALS.2010.12.059 · DOI
- 10.1016/j.jconrel.2009.10.002 · DOI
- 10.1021/acsnano.5b06939 · DOI · Paper page
- 10.7150/ntno.30052 · DOI
- 10.1021/nl400188q · DOI
- 10.1063/1.478435 · DOI
- 10.1002/btm2.10049 · DOI
- 10.1002/adfm.201602189 · DOI
- 10.1016/S0304-8853(02)00706-0 · DOI
- 10.1016/J.JMMM.2005.01.081 · DOI
- 10.1039/C5CC08636A · DOI
- 10.1039/C5NR03777H · DOI
- 10.3390/nano8110935 · DOI
- 10.1021/nn102762f · DOI
- 10.2217/nnm.12.109 · DOI
- 10.1002/wnan.1311 · DOI
- 10.1016/J.DRUDIS.2016.09.013 · DOI
- 10.1016/J.DRUDIS.2015.05.009 · DOI
- 10.1177/0963689717715824 · DOI
- 10.1016/j.nano.2014.11.009 · DOI
- 10.1016/J.YEXMP.2008.12.004 · DOI
- 10.1016/J.COLSURFB.2015.04.030 · DOI
- 10.1038/nrd4519 · DOI
- 10.1016/J.CCR.2009.10.013 · DOI
- 10.1016/j.addr.2008.03.018 · DOI
- 10.1021/ja0380852 · DOI
- 10.3390/ma9070554 · DOI
- 10.1039/C6CC02972H · DOI
- Tipler P., 1999, Physics for scientists and engineers
- 10.1021/acs.chemrev.5b00589 · DOI
- 10.1021/acsnano.7b00609 · DOI
- 10.1016/J.ADDR.2015.12.020 · DOI
- Vaupel P., 1989, Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review, Cancer Research, 49, 6449
- 10.1021/acsami.6b15811 · DOI
- 10.1016/J.CARBPOL.2011.08.091 · DOI
- 10.2214/ajr.152.1.167 · DOI
- 10.1039/C3NR04421A · DOI
- 10.1038/natrevmats.2016.14 · DOI · Paper page
- 10.1073/pnas.1018382108 · DOI
- 10.1021/acs.langmuir.6b00842 · DOI
- 10.1002/anie.201305883 · DOI
- 10.1016/J.JMMM.2014.09.035 · DOI
- 10.18632/oncotarget.9116 · DOI
- 10.1002/anie.201306557 · DOI
- 10.1038/nnano.2016.168 · DOI · Paper page
Cited by
Sorted by citations
Tomitaka, A., Vashist, A., Kolishetti, N., & Nair, M. (2023) · Nanoscale Advances · doi:10.1039/d3na00180f · Cited by 45
El-khawaga, A. M., Youssef, O. I., El-dydamoni, O. A., Ragab, W. M., & Mohammed, R. A. E. (2026) · European Journal of Medical Research · doi:10.1186/s40001-025-03804-9 · Cited by 14
Metadata
- Authors
- Liu, J. F., Jang, B., Issadore, D., & Tsourkas, A.
- Venue
- WIREs Nanomedicine and Nanobiotechnology
- Publisher
- Wiley
- Published
- 2019-06-26
- Volume
- 11
- Issue
- 6
- ISSN
- 1939-5116
- 1939-0041
- PMC
- PMC6788948
- Cited by
- 265
- References
- 14
- Language
- en
- Funders
- Brain and Behavior Research Foundation
- National Cancer Institute (R01 CA181429)
- National Institute of Biomedical Imaging and Bioengineering (R21 EB023989)
- National Institute of Neurological Disorders and Stroke (T32 NS091006)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review